The largest database of trusted experimental protocols

Xenogen ivis lumina bioluminescence imaging system

Manufactured by PerkinElmer

The Xenogen IVIS Lumina Bioluminescence Imaging System is a laboratory equipment used for in vivo bioluminescence imaging. It enables the detection and quantification of light emitted from bioluminescent sources within living organisms.

Automatically generated - may contain errors

Lab products found in correlation

2 protocols using xenogen ivis lumina bioluminescence imaging system

1

Bioluminescence Imaging of Tumor Progression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Prior to bioluminescence imaging the region where tumors were located was shaved. Mice were then anesthetized with 2.5% isoflurane in O2, then administered the d-luciferin substrate (150 mg/kg in PBS) by IP injection. Following the injection of the d-luciferin substrate mice, were imaged using the Xenogen IVIS Lumina Bioluminescence Imaging System (PerkinElmer). The peak of luciferase photon flux was recorded 6 minutes after injection of the d-luciferin substrate. The total photon flux was analyzed and restricted to tumor region of interest using Living Image v2.60.1 software (Imaging Systems).
More information regarding human TYMS and DHFR preparation, tritium-based TYMS catalytic activity assay, competitive drug displacement assay, DHFR activity assay, initial computational screening for potential inhibitors, and molecular modeling of the proposed inhibition modes is provided in Supplemental Methods.
+ Open protocol
+ Expand
2

Subcutaneous and Intraperitoneal Xenograft Mouse Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
Luc-PANC-1 (5 × 106) and Luc-CM (0.5 × 106) cells were resuspended in 200 μL of PBS and injected subcutaneously or IP, respectively, into 6- to 8-week-old NSG mice. Tumor-bearing mice were imaged using Xenogen IVIS Lumina Bioluminescence Imaging System (PerkinElmer) every week after cell injection. Luc-PANC-1– and Luc-CM–injected mice were randomized based on slope of luciferase signal at 28 days and 24 days, respectively, and treatment was initiated. Mice received daily 19-S or 19-S7 at the indicated doses by IP injection or by oral gavage (PO), and vehicle control mice received corn oil. For all animals, body weight was recorded weekly, and Luc-PANC-1 tumor volume was measured weekly with a caliper. For scheduled sacrifice experiments, animals were euthanized after 4 weeks of treatment. For survival studies, animals were sacrificed when tumors reached 1,500 mm3 or when they showed any signs of ulceration. Harvested tumors were excised and weighed, then fixed in alcoholic formalin (67.5% ethanol, 10% formaldehyde 37%, 22.5% water) for pathology analysis. Tumor volume was calculated as volume = 0.52(length × width2).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!